Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery

Gabriele Ghetti1, Francesco Chietera, Francesco Donati

  • 1Department of Cardiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S Orsola-Malpighi, Bologna, Italy.

Insights

Coronary artery ectasia (CAE) extension is similar across various clinical settings. However, patients with myocardial infarction without obstructive coronary artery disease (MINOCA) showed more extensive CAE.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Coronary artery ectasia (CAE) is a condition with several reported causes, primarily atherosclerosis and tunica media abnormalities.
  • Understanding the factors influencing CAE extension is crucial for patient management.

Purpose of the Study:

  • To investigate whether the extension of coronary artery ectasia (CAE) differs across distinct clinical settings.
  • To explore the relationship between clinical diagnosis and CAE extension.

Main Methods:

  • A retrospective analysis of 341 patients with CAE from 9659 coronary angiographies.
  • Patients were categorized by admission diagnosis: stable/unstable angina (S-UA), myocardial infarction (MI), aortic disease, or aortic valvular disease (AVD).
  • Subgroup analysis for S-UA and MI based on obstructive coronary artery disease (OCAD); multivariable logistic regression used to assess CAE extension (Markis classification, number of affected vessels).

Main Results:

  • No significant differences in CAE extension (vessels affected or Markis class) were observed among the four main clinical groups.
  • CAE extension was not directly related to the extent of obstructive coronary artery disease (OCAD) as measured by the Gensini score.
  • Patients with myocardial infarction without obstructive coronary artery disease (MINOCA) showed a significantly higher extension of CAE (Markis class 1).

Conclusions:

  • The extension of coronary artery ectasia (CAE) is comparable across different clinical scenarios, including S-UA, MI, aortic disease, and AVD.
  • Patients presenting with MINOCA demonstrate a greater extension of CAE, highlighting a specific clinical association.
  • This finding suggests that MINOCA may be a significant factor associated with more severe CAE extension.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
49
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
20
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
21